Adverse left ventricular remodeling by glycoprotein nonmetastatic melanoma protein B in myocardial infarction
Open Access
- 25 October 2016
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 31 (2) , 556-568
Abstract
Cardiac diseases are the leading cause of death. Available treatment approaches are not sufficient to reverse persistent cardiac damage after injury; thus, the search for new therapeutic targets is essential. Our microarray‐based screening in rat hearts 24 h after myocardial infarction (MI) yielded glycoprotein nonmetastatic melanoma protein B (GPNMB), which is known to be involved in inflammation and fibrosis after tissue injury. However, its role in the heart was elusive. We found increased cardiac expression levels of GPNMB in rats and mice after MI. Analysis of DBA/2J mice, which lack functional GPNMB due to a spontaneous point mutation, showed that systemic GPNMB deficiency was associated with preserved cardiac function and less left ventricular dilation after MI compared with DBA/2J mice with reconstituted GPNMB expression. These improvements were associated with decreased expression of matrix metalloproteinase 9, the cardiac stress genes for natriuretic peptides (atrial natriuretic peptide and brain natriuretic peptide), and β‐myosin heavy chain after MI. Moreover, GPNMB deficiency attenuated the dilated cardiomyopathy in muscle lim protein knockout mice but could not prevent cardiac hypertrophy induced by isoprenaline infusion. This is the first experimental study to show that GPNMB adversely influences myocardial remodeling.—Jühlstedt, S., Qadri, F., Nickl, B., Schulz, H., HÖzcelik, C., Bader, M. Adverse left ventricular remodeling by glycoprotein nonmetastatic melanoma protein B in myocardial infarction. FASEB J. 31, 556–568 (2017). www.fasebj.orgKeywords
This publication has 63 references indexed in Scilit:
- Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosisJournal of Neuroscience Research, 2015
- Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia–reperfusion injuryNeuroscience, 2014
- Induction of Matrix Metalloproteinase-3 (MMP-3) Expression in the Microglia by Lipopolysaccharide (LPS) via Upregulation of Glycoprotein Nonmetastatic Melanoma B (GPNMB) ExpressionJournal of Molecular Neuroscience, 2014
- ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic PropertiesPLOS ONE, 2010
- Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome‐specific and proteolytically released proteinThe FASEB Journal, 2010
- Osteoactivin fragments produced by ectodomain shedding induce MMP‐3 expression via ERK pathway in mouse NIH‐3T3 fibroblastsFEBS Letters, 2007
- Overexpression of osteoactivin protects skeletal muscle from severe degeneration caused by long-term denervation in miceThe Journal of Medical Investigation, 2007
- Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in miceAmerican Journal of Physiology-Cell Physiology, 2005
- Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer ModelJournal of Biological Chemistry, 2003
- nmb, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenograftsInternational Journal of Cancer, 1995